{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:45:30Z","timestamp":1771645530156,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1953,2,1]],"date-time":"1953-02-01T00:00:00Z","timestamp":-533779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1953,2,1]],"date-time":"1953-02-01T00:00:00Z","timestamp":-533779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1953,2]]},"DOI":"10.1016\/0002-9343(53)90017-5","type":"journal-article","created":{"date-parts":[[2004,4,20]],"date-time":"2004-04-20T07:49:58Z","timestamp":1082447398000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Malignant hypertension and hypertensive encephalopathy"],"prefix":"10.1016","volume":"14","author":[{"given":"John H.","family":"Moyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam I.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur B.","family":"Tashnek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russel O.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(53)90017-5_BIB1","series-title":"A Treatise on Therapeutics Comprising Materia Medica and Toxicology with Especial Reference to the Physiological Action of Drugs to Clinical Medicine","author":"Wood","year":"1874"},{"key":"10.1016\/0002-9343(53)90017-5_BIB2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archinte.1915.00080010059004","article-title":"The clinical action of veratrum","volume":"16","author":"Collins","year":"1915","journal-title":"Arch. Int. Med."},{"key":"10.1016\/0002-9343(53)90017-5_BIB3","series-title":"The Pharmacological Basis of Therapeutics","author":"Goodman","year":"1940"},{"key":"10.1016\/0002-9343(53)90017-5_BIB4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.1949.02900380001001","article-title":"Essential hypertension","volume":"140","author":"Wilkins","year":"1949","journal-title":"J. A. M. A."},{"key":"10.1016\/0002-9343(53)90017-5_BIB5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1172\/JCI102078","article-title":"The hemodynamic effects of hypotensive drugs in man. 1. Veratrum viride","volume":"28","author":"Freis","year":"1949","journal-title":"J. Clin. Investigation"},{"key":"10.1016\/0002-9343(53)90017-5_BIB6","first-page":"302","article-title":"Essential hypertension, therapeutic trial of veriloid, a new extract of veratrum viride","volume":"72","author":"Wilkins","year":"1949"},{"key":"10.1016\/0002-9343(53)90017-5_BIB7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0002-8703(48)90236-1","article-title":"A clinical evaluation of veratrum viride in the treatment of essential hypertension","volume":"36","author":"Freis","year":"1948","journal-title":"Am. Heart J."},{"key":"10.1016\/0002-9343(53)90017-5_BIB8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-8703(50)90321-8","article-title":"A prolonged study of oral veratrum viride in the treatment of essential hypertension","volume":"40","author":"McNair","year":"1950","journal-title":"Am. Heart J."},{"key":"10.1016\/0002-9343(53)90017-5_BIB9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0002-8703(51)90263-3","article-title":"The use of purified veratrum viride alkaloids in the treatment of essential hypertension","volume":"41","author":"Borrow","year":"1951","journal-title":"Am. Heart J."},{"key":"10.1016\/0002-9343(53)90017-5_BIB10","first-page":"725","article-title":"Veriloid, a new hypotensive extract of veratrum viride","volume":"71","author":"Stutzman","year":"1949"},{"key":"10.1016\/0002-9343(53)90017-5_BIB11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI101994","article-title":"The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure, and normal values","volume":"27","author":"Kety","year":"1948","journal-title":"J. Clin. Investigation"},{"key":"10.1016\/0002-9343(53)90017-5_BIB12","first-page":"537","article-title":"Further experiences with veratrone in the treatment of eclampsia","volume":"2","author":"Haultain","year":"1914","journal-title":"Brit. M. J."},{"key":"10.1016\/0002-9343(53)90017-5_BIB13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9378(16)39646-6","article-title":"The treatment of eclampsia and preeclampsia with veratrum viride and magnesium sulfate","volume":"54","author":"Irving","year":"1947","journal-title":"Am. J. Obst. & Gynec."},{"key":"10.1016\/0002-9343(53)90017-5_BIB14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.1940.02810420019006","article-title":"Veratrum viride in the treatment of eclampsia","volume":"115","author":"Bryant","year":"1940","journal-title":"J. A. M. A."},{"key":"10.1016\/0002-9343(53)90017-5_BIB15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3565(25)08319-3","article-title":"On the action of veratrum viride","volume":"7","author":"Cramer","year":"1915","journal-title":"J. Pharmacol. & Exper. Therap."},{"key":"10.1016\/0002-9343(53)90017-5_BIB16","first-page":"339","article-title":"Site of cardiovascular action of hypotensive veratrum derivatives","volume":"10","author":"Swiss","year":"1951"},{"key":"10.1016\/0002-9343(53)90017-5_BIB17","unstructured":"Mills, L. C., Moyer, J. H. and Miller, S. I. Unpublished data."},{"key":"10.1016\/0002-9343(53)90017-5_BIB18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3565(25)08326-0","article-title":"Studies on the vasomotor center. XVIII. The effects of veratrum viride and cevadin","volume":"7","author":"Pilcher","year":"1915","journal-title":"J. Pharmacol. & Exper. Therap."},{"key":"10.1016\/0002-9343(53)90017-5_BIB19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archinte.1951.03810060016002","article-title":"Effects of veriloid on essential hypertension","volume":"87","author":"Gropper","year":"1951","journal-title":"Arch. Int. Med."},{"key":"10.1016\/0002-9343(53)90017-5_BIB20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(25)07708-0","article-title":"The emetic properties of veratrum derivatives","volume":"104","author":"Swiss","year":"1952","journal-title":"J. Pharmacol. & Exper. Therap."},{"key":"10.1016\/0002-9343(53)90017-5_BIB21","unstructured":"Huggins, R. A. Personal communication."},{"key":"10.1016\/0002-9343(53)90017-5_BIB22","first-page":"32","article-title":"Effects of protoveratrine on cerebral hemodynamics and oxygen metabolism in hypertensive subjects","volume":"10","author":"Crumpton","year":"1951"},{"key":"10.1016\/0002-9343(53)90017-5_BIB23","article-title":"Effects of 1-hydrazinophthalazine on cerebral hemodynamics and oxygen metabolism in hypertensive subjects","author":"Hafkenschiel","year":"1951","journal-title":"Abstr. Am. Soc. Pharm. & Exper. Therap."},{"key":"10.1016\/0002-9343(53)90017-5_BIB24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1172\/JCI102273","article-title":"The effects of dihydroergocornine on the cerebral circulation of patients with essential hypertension","volume":"19","author":"Hafkenschiel","year":"1950","journal-title":"J. Clin. Investigation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934353900175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934353900175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T06:39:29Z","timestamp":1756881569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002934353900175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1953,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1953,2]]}},"alternative-id":["0002934353900175"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(53)90017-5","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1953,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant hypertension and hypertensive encephalopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(53)90017-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1953 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}